Pr. Hansen et al., Aminoguanidine induces constrictive vascular remodeling and inhibits smooth muscle cell death after balloon injury, EUR J PHARM, 372(2), 1999, pp. 157-166
We examined the effects of aminoguanidine, an inhibitor of inducible nitric
oxide synthase, in the rat model of balloon injury, Arteries were assessed
by histomorphometry, and vascular smooth muscle cell death and proliferati
on were examined 24 h and 14 days after balloon injury by in situ terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) of fra
gmented DNA and expression of proliferating cell nuclear antigen, respectiv
ely. Aminoguanidine decreased the luminal area 14 days after balloon injury
(0.19 +/- 0.04 mm(2) vs. 0.35 +/- 0.02 mm(2); P < 0.005), and this effect
was attributable to reduction of the total vessel area, i.e., constrictive
vascular remodeling (0.42 +/- 0.03 mm(2) vs. 0.55 +/- 0.03 mm2; P < 0.005).
At 24 h after injury, the percentage of TUNEL-positive cells in the medial
layer was reduced by aminoguanidine (2.0 +/- 1.0% vs. 17.3 +/- 5.4%; P < 0
.05), and the percentage of proliferating cells was increased (18.4 +/- 5.5
% vs. 4.9 +/- 2.2%; P < 0.05). Aminoguanidine did not influence the density
of VSMC nuclei in the injured artery wall, systemic blood pressure or endo
thelium-dependent vasorelaxation. We conclude, that in the rat model of bal
loon injury, aminoguanidine induces luminal loss by constrictive vascular r
emodeling in association with reduced early VSMC death and increased prolif
eration. (C) 1999 Elsevier Science B.V. All rights reserved.